Your Location Within Site:
Pharmaceuticals and biotechnology
Drug discovery and development
IRL has specialist chemical and biochemical expertise for the discovery of new drug candidates to target a range of conditions and diseases. We also have dedicated bioprocessing expertise for the necessary assessment of new drug candidates including impurity and identity specification and calibration and assay testing in drug metabolism studies at scales ranging from milligram to gram quantities.
Some of the cutting edge research programmes our world class Carbohydrate Chemistry group is actively engaged in include:
Glycotherapeutics
We are a world leader in the niche area of glycotherapeutics, discovering new drug treatments from carbohydrate materials. Read more >>
Carbohydrate nanotechnology
This programme will isolate, synthesise, formulate and test new carbohydrate-containing chemical entities to identify potential adjuvant candidates for the development of novel, more effective, cell-mediated vaccines. Read more >>
Chiral scaffolds
We have developed world-leading expertise in ‘iminosugar’ chemistry through our highly successful programme of drug discovery. This expertise has now been directed towards building a library of novel chiral scaffolds for the pharmaceutical industry. Read more >>
New synthesis methodologies
We are researching ways of synthesising compounds known as sulphated oligosaccharides that play an important role in biological systems. Read more >>